The Value of FDG PET/CT in Treatment Response Assessment, Follow-Up, and Surveillance of Lung Cancer.
Publication
, Journal Article
Sheikhbahaei, S; Mena, E; Yanamadala, A; Reddy, S; Solnes, LB; Wachsmann, J; Subramaniam, RM
Published in: AJR Am J Roentgenol
February 2017
OBJECTIVE: The purpose of this article is to summarize the evidence regarding the role of FDG PET/CT in treatment response assessment and surveillance of lung cancer and to provide suggested best practices. CONCLUSION: FDG PET/CT is a valuable imaging tool for assessing treatment response for patients with lung cancer, though evidence for its comparative effectiveness with chest CT is still evolving. FDG PET/CT is most useful when there is clinical suspicion or other evidence for disease recurrence or metastases. The sequencing, cost analysis, and comparative effectiveness of FDG PET/CT and conventional imaging modalities in the follow-up setting need to be investigated.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
AJR Am J Roentgenol
DOI
EISSN
1546-3141
Publication Date
February 2017
Volume
208
Issue
2
Start / End Page
420 / 433
Location
United States
Related Subject Headings
- Treatment Outcome
- Survival Rate
- Sensitivity and Specificity
- Reproducibility of Results
- Radiopharmaceuticals
- Positron Emission Tomography Computed Tomography
- Outcome Assessment, Health Care
- Nuclear Medicine & Medical Imaging
- Neoplasm Recurrence, Local
- Male
Citation
APA
Chicago
ICMJE
MLA
NLM
Sheikhbahaei, S., Mena, E., Yanamadala, A., Reddy, S., Solnes, L. B., Wachsmann, J., & Subramaniam, R. M. (2017). The Value of FDG PET/CT in Treatment Response Assessment, Follow-Up, and Surveillance of Lung Cancer. AJR Am J Roentgenol, 208(2), 420–433. https://doi.org/10.2214/AJR.16.16532
Sheikhbahaei, Sara, Esther Mena, Anusha Yanamadala, Siddaling Reddy, Lilja B. Solnes, Jason Wachsmann, and Rathan M. Subramaniam. “The Value of FDG PET/CT in Treatment Response Assessment, Follow-Up, and Surveillance of Lung Cancer.” AJR Am J Roentgenol 208, no. 2 (February 2017): 420–33. https://doi.org/10.2214/AJR.16.16532.
Sheikhbahaei S, Mena E, Yanamadala A, Reddy S, Solnes LB, Wachsmann J, et al. The Value of FDG PET/CT in Treatment Response Assessment, Follow-Up, and Surveillance of Lung Cancer. AJR Am J Roentgenol. 2017 Feb;208(2):420–33.
Sheikhbahaei, Sara, et al. “The Value of FDG PET/CT in Treatment Response Assessment, Follow-Up, and Surveillance of Lung Cancer.” AJR Am J Roentgenol, vol. 208, no. 2, Feb. 2017, pp. 420–33. Pubmed, doi:10.2214/AJR.16.16532.
Sheikhbahaei S, Mena E, Yanamadala A, Reddy S, Solnes LB, Wachsmann J, Subramaniam RM. The Value of FDG PET/CT in Treatment Response Assessment, Follow-Up, and Surveillance of Lung Cancer. AJR Am J Roentgenol. 2017 Feb;208(2):420–433.
Published In
AJR Am J Roentgenol
DOI
EISSN
1546-3141
Publication Date
February 2017
Volume
208
Issue
2
Start / End Page
420 / 433
Location
United States
Related Subject Headings
- Treatment Outcome
- Survival Rate
- Sensitivity and Specificity
- Reproducibility of Results
- Radiopharmaceuticals
- Positron Emission Tomography Computed Tomography
- Outcome Assessment, Health Care
- Nuclear Medicine & Medical Imaging
- Neoplasm Recurrence, Local
- Male